rs75385605

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004836.7(EIF2AK3):​c.1756A>T​(p.Ile586Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00175 in 1,609,122 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0092 ( 19 hom., cov: 32)
Exomes 𝑓: 0.00097 ( 23 hom. )

Consequence

EIF2AK3
NM_004836.7 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 1.10
Variant links:
Genes affected
EIF2AK3 (HGNC:3255): (eukaryotic translation initiation factor 2 alpha kinase 3) The protein encoded by this gene phosphorylates the alpha subunit of eukaryotic translation-initiation factor 2, leading to its inactivation, and thus to a rapid reduction of translational initiation and repression of global protein synthesis. This protein is thought to modulate mitochondrial function. It is a type I membrane protein located in the endoplasmic reticulum (ER), where it is induced by ER stress caused by malfolded proteins. Mutations in this gene are associated with Wolcott-Rallison syndrome. [provided by RefSeq, Sep 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004467219).
BP6
Variant 2-88583437-T-A is Benign according to our data. Variant chr2-88583437-T-A is described in ClinVar as [Benign]. Clinvar id is 128983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0092 (1401/152220) while in subpopulation AFR AF= 0.0319 (1323/41528). AF 95% confidence interval is 0.0304. There are 19 homozygotes in gnomad4. There are 622 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 19 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EIF2AK3NM_004836.7 linkc.1756A>T p.Ile586Leu missense_variant Exon 10 of 17 ENST00000303236.9 NP_004827.4 Q9NZJ5B3KY45

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EIF2AK3ENST00000303236.9 linkc.1756A>T p.Ile586Leu missense_variant Exon 10 of 17 1 NM_004836.7 ENSP00000307235.3 Q9NZJ5

Frequencies

GnomAD3 genomes
AF:
0.00920
AC:
1400
AN:
152102
Hom.:
19
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0319
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00430
GnomAD3 exomes
AF:
0.00246
AC:
617
AN:
250768
Hom.:
9
AF XY:
0.00171
AC XY:
232
AN XY:
135542
show subpopulations
Gnomad AFR exome
AF:
0.0339
Gnomad AMR exome
AF:
0.00139
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000115
Gnomad OTH exome
AF:
0.000818
GnomAD4 exome
AF:
0.000973
AC:
1418
AN:
1456902
Hom.:
23
Cov.:
30
AF XY:
0.000818
AC XY:
593
AN XY:
725160
show subpopulations
Gnomad4 AFR exome
AF:
0.0345
Gnomad4 AMR exome
AF:
0.00186
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000451
Gnomad4 OTH exome
AF:
0.00211
GnomAD4 genome
AF:
0.00920
AC:
1401
AN:
152220
Hom.:
19
Cov.:
32
AF XY:
0.00836
AC XY:
622
AN XY:
74422
show subpopulations
Gnomad4 AFR
AF:
0.0319
Gnomad4 AMR
AF:
0.00419
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00425
Alfa
AF:
0.000682
Hom.:
3
Bravo
AF:
0.0108
ESP6500AA
AF:
0.0320
AC:
141
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00317
AC:
385
Asia WGS
AF:
0.00115
AC:
4
AN:
3476
EpiCase
AF:
0.000109
EpiControl
AF:
0.00

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 05, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Wolcott-Rallison dysplasia Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Nov 22, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance: Likely benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Monogenic diabetes Benign:1
Jan 25, 2019
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: research

ACMG criteria: BA1 (3.3% in gnomAD African), BS2 (14 homozygotes in gnomAD), BP4 (REVEL 0.125 + 10 predictors)=benign -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
16
DANN
Benign
0.80
DEOGEN2
Benign
0.14
.;T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.4
FATHMM_MKL
Uncertain
0.80
D
LIST_S2
Uncertain
0.87
.;D;.
MetaRNN
Benign
0.0045
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
.;N;.
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.44
N;N;N
REVEL
Benign
0.13
Sift
Benign
0.070
T;T;T
Sift4G
Benign
0.37
T;T;.
Polyphen
0.010
.;B;.
Vest4
0.31
MutPred
0.37
.;Loss of catalytic residue at I586 (P = 0.0094);.;
MVP
0.69
MPC
0.34
ClinPred
0.0019
T
GERP RS
-3.8
Varity_R
0.13
gMVP
0.65

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs75385605; hg19: chr2-88882955; API